Skip to Main Content

Author Details

Edouard C Nice
Monash University
1971
308
68
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37973552HSPA8 Activates Wnt/β-Catenin Signaling to Facilitate BRAF V600E Colorectal Cancer Progression by CMA-Mediated CAV1 Degradation.Adv Sci (Weinh)2024
37973552HSPA8 Activates Wnt/β-Catenin Signaling to Facilitate BRAF V600E Colorectal Cancer Progression by CMA-Mediated CAV1 Degradation.Adv Sci (Weinh)2024
37792154Redox signaling-mediated tumor extracellular matrix remodeling: pleiotropic regulatory mechanisms.Cell Oncol (Dordr)2024
37792154Redox signaling-mediated tumor extracellular matrix remodeling: pleiotropic regulatory mechanisms.Cell Oncol (Dordr)2024
36318223The 2022 Report on the Human Proteome from the HUPO Human Proteome Project.J Proteome Res2023
35973552Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling.J Adv Res2023
36399643Brain-Targeted HFn-Cu-REGO Nanoplatform for Site-Specific Delivery and Manipulation of Autophagy and Cuproptosis in Glioblastoma.Small2023
36318223The 2022 Report on the Human Proteome from the HUPO Human Proteome Project.J Proteome Res2023
38045829Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy.MedComm (2020)2023
37742011Laser-activatable oxygen self-supplying nanoplatform for efficiently overcoming colorectal cancer resistance by enhanced ferroptosis and alleviated hypoxic microenvironment.Biomater Res2023
37736748Oral squamous cell carcinomas: state of the field and emerging directions.Int J Oral Sci2023
37471054Periplocin suppresses the growth of colorectal cancer cells by triggering LGALS3 (galectin 3)-mediated lysophagy.Autophagy2023
36899444Nano-Econazole Enhanced PD-L1 Checkpoint Blockade for Synergistic Antitumor Immunotherapy against Pancreatic Ductal Adenocarcinoma.Small2023
37206879Carrier-free delivery of thymopentin-regulated injectable nanogels via an enhanced cancer immunity cycle against melanoma metastasis.Mater Today Bio2023
36823188PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma.Nat Commun2023
37460404Drug Repurposing-Based Brain-Targeting Self-Assembly Nanoplatform Using Enhanced Ferroptosis against Glioblastoma.Small2023
36565657CCT251545 enhances drug delivery and potentiates chemotherapy in multidrug-resistant cancers by Rac1-mediated macropinocytosis.Drug Resist Updat2023
36694209Protein degradation: expanding the toolbox to restrain cancer drug resistance.J Hematol Oncol2023
36736962Protein persulfidation: Rewiring the hydrogen sulfide signaling in cell stress response.Biochem Pharmacol2023
36538368Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer.ACS Appl Mater Interfaces2023
37229829Proteolysis-targeting chimeras in biotherapeutics: Current trends and future applications.Eur J Med Chem2023
36849442Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment.Bone Res2023
36788227Targeting PSAT1 to mitigate metastasis in tumors with p53-72Pro variant.Signal Transduct Target Ther2023
36670444Site-specific nanomodulator capable of modulation apoptosis for enhanced colorectal cancer chemo-photothermal therapy.J Nanobiotechnology2023
37507782Sertaconazole-repurposed nanoplatform enhances lung cancer therapy via CD44-targeted drug delivery.J Exp Clin Cancer Res2023
37507782Sertaconazole-repurposed nanoplatform enhances lung cancer therapy via CD44-targeted drug delivery.J Exp Clin Cancer Res2023
37742011Laser-activatable oxygen self-supplying nanoplatform for efficiently overcoming colorectal cancer resistance by enhanced ferroptosis and alleviated hypoxic microenvironment.Biomater Res2023
37736748Oral squamous cell carcinomas: state of the field and emerging directions.Int J Oral Sci2023
38045829Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy.MedComm (2020)2023
37460404Drug Repurposing-Based Brain-Targeting Self-Assembly Nanoplatform Using Enhanced Ferroptosis against Glioblastoma.Small2023
37206879Carrier-free delivery of thymopentin-regulated injectable nanogels via an enhanced cancer immunity cycle against melanoma metastasis.Mater Today Bio2023
37229829Proteolysis-targeting chimeras in biotherapeutics: Current trends and future applications.Eur J Med Chem2023
37471054Periplocin suppresses the growth of colorectal cancer cells by triggering LGALS3 (galectin 3)-mediated lysophagy.Autophagy2023
36788227Targeting PSAT1 to mitigate metastasis in tumors with p53-72Pro variant.Signal Transduct Target Ther2023
36694209Protein degradation: expanding the toolbox to restrain cancer drug resistance.J Hematol Oncol2023
36849442Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment.Bone Res2023
36399643Brain-Targeted HFn-Cu-REGO Nanoplatform for Site-Specific Delivery and Manipulation of Autophagy and Cuproptosis in Glioblastoma.Small2023
36538368Carrier-Free Nanoplatform via Evoking Pyroptosis and Immune Response against Breast Cancer.ACS Appl Mater Interfaces2023
36736962Protein persulfidation: Rewiring the hydrogen sulfide signaling in cell stress response.Biochem Pharmacol2023
36899444Nano-Econazole Enhanced PD-L1 Checkpoint Blockade for Synergistic Antitumor Immunotherapy against Pancreatic Ductal Adenocarcinoma.Small2023
36670444Site-specific nanomodulator capable of modulation apoptosis for enhanced colorectal cancer chemo-photothermal therapy.J Nanobiotechnology2023
36565657CCT251545 enhances drug delivery and potentiates chemotherapy in multidrug-resistant cancers by Rac1-mediated macropinocytosis.Drug Resist Updat2023
36823188PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerability in hepatocellular carcinoma.Nat Commun2023
35973552Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling.J Adv Res2023
32745541The status of proteomics as we enter the 2020s: Towards personalised/precision medicine.Anal Biochem2022
36105204Drug repurposing in cancer neuroscience: From the viewpoint of the autophagy-mediated innervated niche.Front Pharmacol2022
36230492Targeting Glucose Metabolism Enzymes in Cancer Treatment: Current and Emerging Strategies.Cancers (Basel)2022
35386842Redox signaling at the crossroads of human health and disease.MedComm (2020)2022
36096856Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies.J Hematol Oncol2022
35501823Nanoengineering a metal-organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells.J Exp Clin Cancer Res2022
  • 1 - 50 of 616

Recommended Authors

Ioannis Prassas
Mount Sinai Hospital
Career Start Year 2007
Number of shared co-authors 0
Wendy Sandoval
Genentech Inc.
Career Start Year 2006
Number of shared co-authors 8
Henrik J Johansson
Karolinska Institutet
Career Start Year 2005
Number of shared co-authors 3
Chong-Feng Xu
Biogen Inc.
Career Start Year 2004
Number of shared co-authors 0
Brian L Hood
The Henry M. Jackson Foundation for the Advancement of Military Medicine
Career Start Year 2004
Number of shared co-authors 4
Sharon J Pitteri
Stanford University
Career Start Year 2003
Number of shared co-authors 13
Kieran Wynne
University College Dublin
Career Start Year 2002
Number of shared co-authors 0
Kai St??hler
Universitatsklinikum
Career Start Year 2002
Number of shared co-authors 4
Emily S Boja
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Career Start Year 2000
Number of shared co-authors 18
Parag Mallick
Stanford University
Career Start Year 2000
Number of shared co-authors 15
Thomas P Conrads
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1998
Number of shared co-authors 9
David A Sarracino
Harvard Partners Center For Genetics and Genomics
Career Start Year 1998
Number of shared co-authors 6
Janne Lehti??
Karolinska Institutet
Career Start Year 1997
Number of shared co-authors 7
Jo??lle Vinh
Universite PSL, LPC CNRS UMR8249
Career Start Year 1997
Number of shared co-authors 0
Julius O Nyalwidhe
Eastern Virginia Medical School
Career Start Year 1997
Number of shared co-authors 3
Thomas Kislinger
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1997
Number of shared co-authors 4
Mu Wang
Academy of Pharmacy, Xi'an Jiaotong-Liverpool University
Career Start Year 1996
Number of shared co-authors 3
Byung-Kwon Choi
Baylor College of Medicine
Career Start Year 1995
Number of shared co-authors 1
Tara Hiltke
Office of Cancer Clinical Proteomics Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 14
Nicholas E Sherman
University of Virginia
Career Start Year 1994
Number of shared co-authors 2
Charles E Lyons
Massey Cancer Center, Virginia Commonwealth University
Career Start Year 1992
Number of shared co-authors 0
Petr Nov??k
Institute of Microbiology of the CAS
Career Start Year 1991
Number of shared co-authors 9
Ronald C Hendrickson
Memorial Sloan Kettering Cancer Center
Career Start Year 1990
Number of shared co-authors 7
Emanuel F Petricoin
Center for Applied Proteomics and Molecular Medicine, George Mason University
Career Start Year 1988
Number of shared co-authors 16
Eleftherios P Diamandis
Lunenfeld-Tanenbaum Research Institute
Career Start Year 1981
Number of shared co-authors 6
Steven A Carr
Broad Institute of MIT and Harvard
Career Start Year 1980
Number of shared co-authors 17
Karin D Rodland
Oregon Health and Science University
Career Start Year 1973
Number of shared co-authors 11
John N Weinstein
The University of Texas MD Anderson Cancer Center
Career Start Year 1968
Number of shared co-authors 5
Alma L Burlingame
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1964
Number of shared co-authors 17
John R Yates
TheScripps Research Institute
Career Start Year 1960
Number of shared co-authors 27

Collaborators

Richard J Simpson
Co-authored papers 33
Mark S Baker
Macquarie University
Co-authored papers 19
Robert L Moritz
Institute for Systems Biology
Co-authored papers 16
Lloyd J Old
Ludwig Institute for Cancer Research
Co-authored papers 14
Seong Beom Ahn
Macquarie Medical School, Macquarie University
Co-authored papers 10
Terrance G Johns
Telethon Kids Institute
Co-authored papers 10
William S Hancock
Northeastern University
Co-authored papers 5
Kari Alitalo
Wihuri Research Institute
Co-authored papers 5
Subash Adhikari
Institute of Tibetan Plateau Research, Chinese Academy of Sciences
Co-authored papers 4
Eric W Deutsch
Institute for Systems Biology
Co-authored papers 4
Robert J A Goode
Monash Biomedicine Discovery Institute, Monash University
Co-authored papers 4
Shoba Ranganathan
Macquarie University
Co-authored papers 4
Gilbert S Omenn
and School of Public Health, University of Michigan ann arbor
Co-authored papers 4
Susan Fanayan
Macquarie University
Co-authored papers 4
Qi Dou
The Chinese University of Hong Kong
Co-authored papers 4
Harold A Scheraga
Co-authored papers 4
Martin W Brechbiel
National Institutes of Health
Co-authored papers 3
Emma Lundberg (CM4AI)
Stanford University
Co-authored papers 3
Michael Snyder
Stanford University
Co-authored papers 3
Paul J McMurrick
Co-authored papers 3
Zon Weng Lai
Co-authored papers 3
Fuchu He
International Academy of Phronesis Medicine
Co-authored papers 3
Lydie Lane
SIB Swiss Institute of Bioinformatics and University of Geneva
Co-authored papers 3
Kurt W??thrich
iHuman Institute, ShanghaiTech University
Co-authored papers 3
Gaetano T Montelione
Rensselaer Polytechnic Institute
Co-authored papers 3
Laszlo Otvos
Co-authored papers 3
Young-Ki Paik
College of Life Sciences and Biotechnology, Yonsei University
Co-authored papers 3
Fernando J Corrales
National Center for Biotechnology
Co-authored papers 2
Ileana M Cristea
Princeton University
Co-authored papers 2
Mathias Uhl??n
KTH Royal Institute of Technology
Co-authored papers 2
Release 1.2